Journal article

Molecular insight into targeting the NK cell immune response to cancer

J Rautela, F Souza-Fonseca-Guimaraes, S Hediyeh-Zadeh, RB Delconte, MJ Davis, ND Huntington

Immunology and Cell Biology | WILEY | Published : 2018

Abstract

Natural Killer (NK) cells have long been considered an important part of the anti-tumor immune response due to their potent cytolytic and cytokine-secreting abilities. To date, a clear demonstration of the role NK cells play in human cancer is lacking, and there are still very few examples of therapies that efficiently exploit or enhance the spontaneous ability of NK cells to destroy the autologous cancer cells. Given the paradigm shift toward cancer immunotherapy over the past decade, there is a renewed push to understand how NK cell homeostasis and function are regulated in order to therapeutically harness these cells to treat cancer. This review will highlight recent advancements in our u..

View full abstract

University of Melbourne Researchers

Grants

Awarded by Cancer Research Institute


Funding Acknowledgements

This work is supported by project grants from the National Health and Medical Research Council (NHMRC) of Australia (1049407, 1066770, 1057852, 1027472 to N.D.H), an NHMRC CDF2 fellowship (NDH) as well as an NHMRC Independent Research Institute Infrastructure Support scheme grant and a Victorian State Government Operational Infrastructure Scheme grant. NDH is a recipient of research grants from the following organizations: Ian Potter Foundation (AUS), Tour De Cure (AUS), Harry J Lloyd Charitable Trust (USA), Melanoma Research Alliance (USA) and Cancer Research Institute (USA).